
EnzyQuest is a biotech startup based in Heraklion, Crete, that specializes in developing and commercializing novel enzyme products to enhance manufacturing and analytical processes. They utilize a unique combination of AI and wet-lab techniques to discover enzymes from organisms adapted to extreme conditions, suitable for industrial applications. Their enzymes find use in research, health, and the food industry, with a focus on enabling more efficient and environmentally friendly processes through nature's evolutionary diversity. EnzyQuest has achieved ISO 13485, ISO 9001, and DY8/1348:2004 certifications and received €2.4M in EU funding for the IRIS-COV project, which aims to develop a portable device for combined SARS-CoV-2 and Influenza A testing.

EnzyQuest is a biotech startup based in Heraklion, Crete, that specializes in developing and commercializing novel enzyme products to enhance manufacturing and analytical processes. They utilize a unique combination of AI and wet-lab techniques to discover enzymes from organisms adapted to extreme conditions, suitable for industrial applications. Their enzymes find use in research, health, and the food industry, with a focus on enabling more efficient and environmentally friendly processes through nature's evolutionary diversity. EnzyQuest has achieved ISO 13485, ISO 9001, and DY8/1348:2004 certifications and received €2.4M in EU funding for the IRIS-COV project, which aims to develop a portable device for combined SARS-CoV-2 and Influenza A testing.